Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03699982 · ClinicalTrials.gov registry record · NA
Resting Energy Expenditure in Patients With Cystic Fibrosis: A Pilot Study
A NA study, sponsored by CAMC Health System.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03699982 is a NA study that was terminated before completion, run by CAMC Health System. The registered enrollment target is 10 participants.
The verdict
NCT03699982, a NA study, was terminated before completion, sponsored by CAMC Health System.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Cystic fibrosis is an inherited disorder that causes severe damage to the lungs, digestive system, and other organs in the body. Individuals with cystic fibrosis often have poor weight gain and growth that can negatively impact health further by worsening lung function. Additionally, persons with the disease typically need more than the usual calories on a daily basis. Most institutions estimate these patients' caloric needs using weight, age, and sex based mathematical formulae. However, numerous studies show that use of these formulae often yields inaccurate caloric values. Use of indirect calorimetry may give more accurate estimates of caloric needs in patients with cystic fibrosis. The aim of our study is to assess the accuracy of caloric estimates generated using one such widely used mathematical formula, the Harris-Benedict equation, and to compare this calorie value with that obtained from indirect calorimetry testing in pediatric and adult patients with cystic fibrosis. Study investigators will use the newly calculated caloric requirements in dietary counseling. Changes in weight and lung function after 3 months will be compared to participants' historical changes.
Interventions
- OTHER Daily calorie target based on resting energy expenditure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-10-10 |
| Est. Completion | 2020-01-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03699982
The ClinicalTrials.gov registry entry for NCT03699982 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CAMC Health System, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Daily calorie target based on resting energy expenditure is the first listed.
NCT03699982 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03699982 about?
NCT03699982 is a clinical study titled "Resting Energy Expenditure in Patients With Cystic Fibrosis: A Pilot Study". Cystic fibrosis is an inherited disorder that causes severe damage to the lungs, digestive system, and other organs in the body. Individuals with cystic fibrosis often have poor weight gain and growth that can negatively impact health further by worsening lung function. Additionally, persons with th...
What is the current status of trial NCT03699982?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2018-10-10. Estimated completion is 2020-01-20.
What interventions are being tested in trial NCT03699982?
The interventions under investigation include: Daily calorie target based on resting energy expenditure (OTHER).
Who is sponsoring clinical trial NCT03699982?
This trial is sponsored by CAMC Health System, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.